EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human Metapneumovirus: Emerging Threat in Respiratory Tract Infections

Naga Visalakshi Kaseena, Himasri Puppala, Grace Rajanala Chelsy, Suneetha A, Jahnavi1 Patibandla

International Journal of Zoology, Environment and Life Sciences · 2025

DOI: 10.70604/ijzels.v2i2.70 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Zoology, Environment and Life Sciences, 2025. Verfasst von Naga Visalakshi Kaseena und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Metapneumovirus (HMPV), first identified in 2001, is now recognized as a major viral pathogen responsible for acute respiratory tract infections (ARTIs) globally, particularly affecting infants, the elderly, and immunocompromised individuals. Belonging to the Paramyxoviridae family, HMPV shares structural and clinical similarities with Respiratory Syncytial Virus (RSV), presenting with symptoms ranging from mild upper respiratory tract infections to severe bronchiolitis and pneumonia. Despite its significant clinical burden, no specific antiviral therapy or approved vaccine exists for HMPV, and management is largely supportive. The virus circulates seasonally, peaking in late winter and early spring, with co-infections further complicating diagnosis and treatment. Molecular diagnostics such as RT-PCR are the gold standard for HMPV detection, offering high sensitivity and specificity. Current research focuses on monoclonal antibodies and vaccine development using platforms like mRNA and recombinant protein technology. However, challenges such as immune evasion, genetic variability, underreporting, and limited surveillance systems hinder effective control. Preventive strategies-including infection control practices, early detection, and public health awareness-are crucial in managing outbreaks. Future directions include the development of novel therapeutics, integrated global surveillance, and large-scale vaccine trials. This review consolidates current knowledge on the epidemiology, virology, clinical manifestations, diagnostics, treatment, and prevention of HMPV, emphasizing its growing significance in global respiratory health.

Zitieren

APA

Kaseena, N. V., Puppala, H., Chelsy, G. R., A, S., & Patibandla, J. (2025). Human Metapneumovirus: Emerging Threat in Respiratory Tract Infections. International Journal of Zoology, Environment and Life Sciences. https://doi.org/10.70604/ijzels.v2i2.70

Vancouver

Kaseena NV, Puppala H, Chelsy GR, A S, Patibandla J. Human Metapneumovirus: Emerging Threat in Respiratory Tract Infections. International Journal of Zoology, Environment and Life Sciences. 2025. doi:10.70604/ijzels.v2i2.70

BibTeX
@article{Kaseena2025,
  author = {Kaseena, Naga Visalakshi and Puppala, Himasri and Chelsy, Grace Rajanala and A, Suneetha and Patibandla, Jahnavi1},
  title = {Human Metapneumovirus: Emerging Threat in Respiratory Tract Infections},
  journal = {International Journal of Zoology, Environment and Life Sciences},
  year = {2025},
  doi = {10.70604/ijzels.v2i2.70}
}
Kostenlos starten →